Juan Zhu
Bengbu, 233000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Comparison of four MRI diffusion models to differentiate benign from metastatic retropharyngeal lymph nodes.
Journal: European radiology experimental
Published: February 19, 2025
Halofuginone targets Serine/Glycine synthesis to reverse epidermal growth factor receptor Tyrosine Kinase inhibitor resistance in lung adenocarcinoma.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: November 03, 2024
Experimental study on the inhibitory effect of Halofuginone on NSCLC.
Journal: European journal of pharmacology
Published: July 11, 2024
A comparative evaluation of bioequivalence of Gan & Lee glargine U300 and Toujeo® in Chinese healthy male participants.
Journal: Frontiers in endocrinology
Published: March 27, 2024
Targeted intervention of natural medicinal active ingredients and traditional Chinese medicine on epigenetic modification: Possible strategies for prevention and treatment of atherosclerosis.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: May 22, 2023
Oseltamivir phosphate for suspension is bioequivalent to TAMIFLU in healthy volunteers: a randomized, open-label clinical study.
Journal: BMC pharmacology & toxicology
Published: August 13, 2022
Mass balance, metabolic disposition, and pharmacokinetics of a novel selective inhibitor of PI3Kδ [14C] SHC014748M in healthy Chinese subjects following oral administration.
Journal: Cancer chemotherapy and pharmacology
Published: May 18, 2022
Pharmacokinetic Characteristics, Safety, and Tolerability of Telitacicept, an Injectable Recombinant Human B-Lymphocyte Stimulating Factor Receptor-Antibody Fusion Protein, in Healthy Chinese Subjects.
Journal: Clinical pharmacology in drug development
Published: March 18, 2022
A randomized Phase I pharmacokinetic trial comparing the potential biosimilar trastuzumab (SIBP-01) with the reference product (Herceptin®) in healthy Chinese male volunteers.
Journal: Expert opinion on drug metabolism & toxicology
Published: August 28, 2020
Showing 1-10 of 10
Last Updated: 09/26/2026